KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Long-Term Deferred Tax (2019 - 2025)

Historic Long-Term Deferred Tax for Xenon Pharmaceuticals (XENE) over the last 7 years, with Q3 2025 value amounting to $11.8 million.

  • Xenon Pharmaceuticals' Long-Term Deferred Tax rose 101480.08% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 101480.08%. This contributed to the annual value of $9.7 million for FY2024, which is 110523.69% up from last year.
  • Xenon Pharmaceuticals' Long-Term Deferred Tax amounted to $11.8 million in Q3 2025, which was up 101480.08% from $11.0 million recorded in Q2 2025.
  • Xenon Pharmaceuticals' 5-year Long-Term Deferred Tax high stood at $11.8 million for Q3 2025, and its period low was $207000.0 during Q1 2022.
  • Over the past 5 years, Xenon Pharmaceuticals' median Long-Term Deferred Tax value was $544000.0 (recorded in 2021), while the average stood at $2.7 million.
  • In the last 5 years, Xenon Pharmaceuticals' Long-Term Deferred Tax tumbled by 5972.76% in 2022 and then skyrocketed by 261975.0% in 2025.
  • Quarter analysis of 5 years shows Xenon Pharmaceuticals' Long-Term Deferred Tax stood at $465000.0 in 2021, then rose by 9.46% to $509000.0 in 2022, then skyrocketed by 57.56% to $802000.0 in 2023, then soared by 1105.24% to $9.7 million in 2024, then rose by 21.56% to $11.8 million in 2025.
  • Its Long-Term Deferred Tax was $11.8 million in Q3 2025, compared to $11.0 million in Q2 2025 and $10.9 million in Q1 2025.